PAI1 antibody
Quick Overview for PAI1 antibody (ABIN7536755)
Target
See all PAI1 (SERPINE1) AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Purpose
- PAI-1 - Plasminogen Activator Inhibitor type-1 Polyclonal Antibody
-
Specificity
- Human Plasminogen Activator Inhibitor-1, PAI-1
-
Purification
- Fractionation of IgG from antiserum
-
Immunogen
- Recombinant Plasminogen Activator Inhibitor-1 (PAI-1) prepared from bacterial extracts
-
Isotype
- IgG
-
-
-
-
Application Notes
- Immunoblot 5-25 μg/mL, ELISA capture 20-50 μg/mL
-
Comment
-
Whole IgG is a base level product and refers to IgG antibodies purified from antiserum using multiple precipitation and dialysis steps. The purity of the IgG is typically 90% and is provided in a solution of HEPES buffered saline containing 50% glycerol (v/v). The titre is essentially the same as the starting antiserum and each vial typically contains the amount of IgG recovered from one millilitre of antiserum. This level of product is generally intended for use in applications such as immunoprecipitation, immunoelectrophoresis, immuno-depletion and activity neutralization assays.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Reconstitution
- Allow product to warm to room temperature and gently mix before use
-
Concentration
- 10 mg/mL
-
Buffer
- 10 mM HEPES, pH 7.4, 150 mM NaC, 50 % (v/v) glycerol
-
Storage
- -20 °C
-
Storage Comment
- Store between -10°C and -20°C
-
-
- PAI1 (SERPINE1) (Plasminogen Activator Inhibitor 1 (SERPINE1))
-
Alternative Name
- PAI-1
-
Pathways
- p53 Signaling, Cellular Response to Molecule of Bacterial Origin, Carbohydrate Homeostasis, Autophagy, Smooth Muscle Cell Migration
Target
-